Solventum (SOLV) Competitors $75.56 +1.32 (+1.78%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$74.86 -0.70 (-0.93%) As of 03/27/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, BLCO, INSP, and NARIShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry. Solventum vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew Penumbra Stevanato Group Glaukos Bausch + Lomb Inspire Medical Systems Inari Medical GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, community ranking, analyst recommendations and dividends. Does the MarketBeat Community prefer GEHC or SOLV? GE HealthCare Technologies received 25 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 61.90% of users gave GE HealthCare Technologies an outperform vote while only 4.17% of users gave Solventum an outperform vote. CompanyUnderperformOutperformGE HealthCare TechnologiesOutperform Votes2661.90% Underperform Votes1638.10% SolventumOutperform Votes14.17%Underperform Votes2395.83% Is GEHC or SOLV more profitable? GE HealthCare Technologies has a net margin of 10.13% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies10.13% 25.74% 6.29% Solventum N/A N/A N/A Do analysts rate GEHC or SOLV? GE HealthCare Technologies presently has a consensus target price of $98.75, indicating a potential upside of 20.93%. Solventum has a consensus target price of $79.86, indicating a potential upside of 5.69%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 1 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.77Solventum 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of GEHC or SOLV? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher valuation and earnings, GEHC or SOLV? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.67B1.90$1.99B$4.3318.86Solventum$8.25B1.58$475.72M$2.7527.48 Does the media favor GEHC or SOLV? In the previous week, GE HealthCare Technologies and GE HealthCare Technologies both had 24 articles in the media. GE HealthCare Technologies' average media sentiment score of 1.49 beat Solventum's score of 0.75 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 20 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 13 Very Positive mention(s) 0 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGE HealthCare Technologies beats Solventum on 16 of the 17 factors compared between the two stocks. Remove Ads Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$13.07B$4.41B$5.64B$19.62BDividend YieldN/A32.65%4.56%3.74%P/E Ratio27.4828.8723.1333.60Price / Sales1.5850.00383.8927.47Price / CashN/A51.0838.1617.54Price / BookN/A6.146.944.60Net Income$475.72M$67.64M$3.20B$1.02B7 Day Performance0.77%-1.87%-2.30%-0.16%1 Month Performance-9.47%-0.30%3.10%-1.99%1 Year PerformanceN/A15.24%11.22%4.91% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.0209 of 5 stars$75.56+1.8%$79.86+5.7%N/A$13.07B$8.25B27.4822,000GEHCGE HealthCare Technologies3.71 of 5 stars$81.74+0.3%$98.75+20.8%-9.6%$37.28B$19.67B18.8350,000Dividend AnnouncementPositive NewsPHGKoninklijke Philips3.7596 of 5 stars$25.45-0.1%N/A+26.5%$23.92B$18.02B-30.3078,200Short Interest ↓ZBHZimmer Biomet4.713 of 5 stars$111.25+0.5%$124.15+11.6%-15.4%$22.14B$7.68B25.0018,000Positive NewsSNNSmith & Nephew3.1667 of 5 stars$28.01-0.4%$27.00-3.6%+7.9%$12.24B$5.81B12.9718,452Short Interest ↓PENPenumbra4.4304 of 5 stars$285.59+1.9%$294.47+3.1%+18.9%$11.00B$1.19B839.963,900Insider TradeSTVNStevanato Group1.7052 of 5 stars€22.21-1.3%N/A-36.4%$6.73B$1.10B47.264,650Positive NewsGKOSGlaukos4.4276 of 5 stars$108.09+5.7%$163.25+51.0%+11.8%$6.11B$383.48M-37.66780Insider TradePositive NewsBLCOBausch + Lomb3.9743 of 5 stars$15.90+2.2%$20.00+25.8%-12.9%$5.60B$4.79B-17.4712,500News CoverageGap DownINSPInspire Medical Systems4.8898 of 5 stars$171.03+3.7%$228.82+33.8%-24.6%$5.09B$802.80M98.861,246Positive NewsNARIInari Medical1.0521 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800 Remove Ads Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives NARI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SOLV Stock Free SOLV Stock Alerts